arrow
D

Deborah Collyar

affiliation: patient advocates in research no institution identified.
H指数:30
被引数:5,323

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring

实现对DCIS亚型分类:利用基础模型进行稳健的分级和分子生物标志物评分

2026-05-060
OAAI
Exploring the Priorities of Patients with Early Breast Cancer in the United States: A Qualitative Interview Study and Patient-Informed Conceptual Disease Model

探索美国早期乳腺癌患者的优先事项:一项定性访谈研究和以患者信息为基础的概念性疾病模型

2025-10-310
OAAI
ASO Visual Abstract: Patient-Reported Outcomes After Routine Treatment of In-Situ/Atypical Lesions: The PORTAL Study

ASO可视化摘要:常规治疗原位/非典型病变后的患者报告结局:PORTAL研究

2025-08-250
PRE
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections

急性细菌性皮肤和皮肤结构感染患者健康相关生活质量测量的系统评价

2025-08-151
PRE
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia

医院获得性/呼吸机相关性细菌性肺炎患者健康相关生活质量测量的系统评价

2025-08-151
PRE
Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study

PORTAL研究:常规治疗原位/非典型病变后的患者报告结局

2025-07-270
PRE
Concerted changes in Epithelium and Stroma: a multi-scale, multi-omics analysis of progression from Barrett’s Esophagus to adenocarcinoma

上皮和基质协同变化:从巴雷特食管到腺癌进展的多尺度、多组学分析

2025-07-210
PRE
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols

癌症免疫治疗学会(SITC)关于免疫治疗临床方案关键生物标志物的共识声明

2025-03-071
OA
Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs

使用六项抗菌药物注册试验探索医院获得性细菌性肺炎和呼吸机相关细菌性肺炎的潜在DOOR终点

2024-03-250
OA
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
2023-10-306
OAAI
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
2023-09-225
OA
Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs
2023-04-196
OA